Stock listing

Celyad Oncology Sa

Selected listing: CYAD · EURONEXT · EUR · BE

Celyad Oncology Sa (Euronext:CYAD), Health Technology. Latest release Sep 23, 2026: Celyad Oncology Reports First Half Year 2026 Results.

CYAD:EURONEXTEURBEUpdated October 3, 2026

Ticker: Euronext:CYAD
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Euronext
Currency: EUR

About Celyad Oncology Sa

Celyad Oncology SA is a public company based in Belgium, focused on developing innovative cell therapies for cancer treatment. Celyad is dedicated to advancing its research and development efforts in the oncology field.

Latest news from Celyad Oncology Sa

Celyad Oncology Reports First Half Year 2026 Results

September 23, 2026

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

July 22, 2026

Celyad Oncology : Announces €500,000 Private Placement

July 14, 2026

Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights

April 2, 2026

Celyad Oncology Announces the Sale of C-CATHez ® Catheter

February 12, 2026

All Celyad Oncology Sa news →

Research Celyad Oncology Sa

Celyad Oncology Sa company profile

View the public company page for Celyad Oncology Sa on 6ix.

Celyad Oncology Sa news

Read company news and market updates connected to Celyad Oncology Sa.

Celyad Oncology Sa investor events

Find investor webinars, events, and replay context for Celyad Oncology Sa.